Huang D - Search Results

1

HBV Antigen-Guided Switching Strategy From Nucleos(t)ide Analogue to Interferon: Avoid Virologic Breakthrough and Improve Functional Cure.

Huang D, Yuan Z, Wu D, Yuan W, Chang J, Chen Y, Ning Q, Yan W. Huang D, et al. J Med Virol. 2024 Nov;96(11):e70021. doi: 10.1002/jmv.70021. J Med Virol. 2024. PMID: 39530181

2

Pegylated Interferon-ɑ (IFN-ɑ) Enhances the Inhibitory Effect of Natural Killer Cells on Regulatory T Cells via IFN-γ in Chronic Hepatitis B.

Yuan W, Huang D, Wu D, Chen Y, Ma K, Han M, Luo X, Yan W, Ning Q. Yuan W, et al. Among authors: huang d. J Infect Dis. 2021 Dec 1;224(11):1878-1889. doi: 10.1093/infdis/jiab216. J Infect Dis. 2021. PMID: 33870432

3

Insufficient immunity led to virologic breakthrough in NAs-treated chronic hepatitis B patients switching to Peg-IFN-ɑ.

Huang D, Yan W, Han M, Yuan W, Wang P, Chen Y, Wan X, Luo X, Wu D, Ning Q. Huang D, et al. Antiviral Res. 2022 Jan;197:105220. doi: 10.1016/j.antiviral.2021.105220. Epub 2021 Nov 27. Antiviral Res. 2022. PMID: 34848218

4

End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB.

Huang D, Wu D, Wang P, Wang Y, Yuan W, Hu D, Hu J, Wang Y, Tao R, Xiao F, Zhang X, Wang X, Han M, Luo X, Yan W, Ning Q. Huang D, et al. J Hepatol. 2022 Jul;77(1):42-54. doi: 10.1016/j.jhep.2022.01.021. Epub 2022 Feb 8. J Hepatol. 2022. PMID: 35149125 Free article. Clinical Trial.

5

γδ T Cells Contribute to the Outcome of Murine Fulminant Viral Hepatitis via Effector Cytokines TNF-α and IFN-γ.

Wu D, Yan WM, Wang HW, Huang D, Luo XP, Ning Q. Wu D, et al. Among authors: huang d. Curr Med Sci. 2018 Aug;38(4):648-655. doi: 10.1007/s11596-018-1926-x. Epub 2018 Aug 20. Curr Med Sci. 2018. PMID: 30128874

6

Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection.

Chen Y, Huang D, Yuan W, Chang J, Yuan Z, Wu D, Han M, Luo X, Ning Q, Yan W. Chen Y, et al. Among authors: huang d. Infect Dis Ther. 2021 Dec;10(4):2431-2446. doi: 10.1007/s40121-021-00513-8. Epub 2021 Aug 13. Infect Dis Ther. 2021. PMID: 34387835 Free PMC article.

7

Response to: Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB'.

Wu D, Huang D, Yan W, Ning Q. Wu D, et al. Among authors: huang d. J Hepatol. 2023 Nov;79(5):e204-e206. doi: 10.1016/j.jhep.2023.08.001. Epub 2023 Aug 7. J Hepatol. 2023. PMID: 37558136 No abstract available.

8

Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLD.

Hu D, Wang P, Wang X, Hu X, Huang D, Yan W, Xi D, Han M, Ning Q, Wang H. Hu D, et al. Among authors: huang d. J Formos Med Assoc. 2024 Jul;123(7):773-780. doi: 10.1016/j.jfma.2023.12.001. Epub 2023 Dec 14. J Formos Med Assoc. 2024. PMID: 38097430 Free article.

9

The efficacy of antiviral treatment in chronic hepatitis B patients with hepatic steatosis.

Hu D, Wang P, Wang X, Hu X, Huang D, Yan W, Xi D, Han M, Ning Q, Wang H. Hu D, et al. Among authors: huang d. Heliyon. 2024 Mar 23;10(7):e28653. doi: 10.1016/j.heliyon.2024.e28653. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38590905 Free PMC article.

10

Treg/Th17 imbalance is associated with poor autoimmune hepatitis prognosis.

Liu Y, Yan W, Yuan W, Wang P, Huang D, Luo X, Ning Q. Liu Y, et al. Among authors: huang d. Clin Immunol. 2019 Jan;198:79-88. doi: 10.1016/j.clim.2018.11.003. Epub 2018 Nov 16. Clin Immunol. 2019. PMID: 30453094 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,782 results

Search Page

Filters